Logotype for Seelos Therapeutics Inc

Seelos Therapeutics (SEEL.Q) investor relations material

Seelos Therapeutics Q2 2024 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Seelos Therapeutics Inc
Q2 2024 earnings summary14 Aug, 2024

Executive summary

  • Seelos Therapeutics is a clinical-stage biopharmaceutical company focused on CNS and rare disorders, with lead programs SLS-002 (intranasal ketamine for suicidality in MDD) and SLS-005 (IV trehalose for ALS and SCA).

  • The company announced a strategic focus on mental health and a 33% workforce reduction in April 2024 to reduce costs and extend cash runway.

  • SLS-005 Phase 2/3 ALS trial did not meet primary endpoints but showed efficacy signals in a pre-specified subgroup; SLS-002 Phase II topline data released in September 2023.

  • Ongoing business development efforts include exploring partnerships and collaborations, especially leveraging ketamine expertise.

Financial highlights

  • As of June 30, 2024, cash was $0.3 million, down from $3.0 million at December 31, 2023; accumulated deficit reached $253.6 million.

  • Net income for Q2 2024 was $1.7 million, compared to a net loss of $29.5 million in Q2 2023; net loss for the six months ended June 30, 2024 was $1.0 million, versus $42.9 million loss in the prior year period.

  • Operating expenses for Q2 2024 were $3.5 million, down 69% year-over-year, driven by an 89% reduction in R&D expenses and 8% decrease in G&A.

  • Cash used in operations for the six months ended June 30, 2024 was $5.6 million, compared to $16.3 million in the prior year period.

  • Financing activities provided $2.9 million in the first half of 2024, mainly from equity and warrant issuances.

Outlook and guidance

  • Management believes current cash is insufficient to fund operations for one year beyond the filing date, raising substantial doubt about going concern.

  • The company must raise additional capital to meet obligations, including a minimum cash covenant on its convertible note by October 31, 2024.

  • Strategic focus remains on advancing SLS-002 and SLS-005, with non-essential preclinical work paused.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Seelos Therapeutics, Inc. is a biotechnology company focused on developing treatments for central nervous system disorders and other rare diseases. The company’s research and development efforts target neurological, psychiatric, and neurodegenerative conditions. The company is headquartered in New York, New York, and its shares are listed on the OTCQB.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage